John Lansing's Trending123
John Lansing's Trending123
Username: Password: Login
Trade Talk E-Letter Products & Services Trading Tools Portfolios Members Home
Enter Symbol:
ALEXION PHARMACEUTICALS INC
Drug Manufacturers Other
ALXN @ Yahoo Finance
ALXN Option @ Yahoo Finance
Stock Details
Current Price High Value Change Percent Change Dividend Previous Close
$ 45.08 $ 45.21 $ 0.09 0.20% 0.00 $ 44.99
Opening Price Low Volume Market Cap Average Volume P/E
$ 44.81 $ 44.58 547,439 3.51B 1.09M 0.00
Pivot Table
R2 R1 Pivot S1 S2
45.59 45.34 44.96 44.71 44.33

stock chart

Alexion Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of biologic therapeutic products for the treatment of severe diseases. It develops therapeutic products for the treatment of hematologic and cardiovascular disorders, autoimmune diseases, and cancer; and additional antibody therapeutics for other medical needs. The company primarily develops two lead product candidates, eculizumab and pexelizumab, which address specific diseases that arise when the human immune system produces inflammation in the human body. Eculizumab is in phase III clinical development for treatment of Paroxysmal Nocturnal Hemoglobinuria, a chronic hematologic disease. Pexelizumab is in clinical development for the reduction of the incidence of death, myocardial infarction or heart attack, and other complications associated with coronary artery bypass graft surgery; and for acute myocardial infarction. Alexion Pharmaceuticals has a strategic alliance with Procter and Gamble Pharmaceuticals for the development of pexelizumab. The company was co-founded by Leonard Bell, Stephen P. Squinto, Scott A. Rollins, and Joseph A. Madri in 1992. Alexion Pharmaceuticals is headquartered in Cheshire, Connecticut.

  • Premarket, intraday, nightly, and weekend updates, which include stock picks with full instructions, market direction (short, intermediate, long term), precious metal, commodity, and currency analysis.
  • Provide you stock picks (breakouts) and market direction to help you become
    more profitable.

  • Voice over chart updates sent to you by e-mail. These updates contain stock picks and market status for a number of different portfolios, which Trending123 is recommending and following.
  • Instantaneous e-mail alerts during the trading day when targets have been hit or the status of a position or the market warrants a move. Stock Recommendations for swing traders, day traders, and long term investors.
  • Receive instant emails to your computer, organizer, cell phone of breakouts on stocks.....Learn More